Cargando…
Codependency of Metabolism and Epigenetics Drives Cancer Progression: A Review
Cancer is widely considered to be a set of genetic diseases that are currently classified by tissue and cell type of origin and, increasingly, by its molecular characteristics. This latter aspect is based primarily upon oncogene gains, tumor suppressor losses, and associated transcriptional profiles...
Autores principales: | Masui, Kenta, Harachi, Mio, K. Cavenee, Webster, S. Mischel, Paul, Shibata, Noriyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076272/ https://www.ncbi.nlm.nih.gov/pubmed/32201436 http://dx.doi.org/10.1267/ahc.20002 |
Ejemplares similares
-
Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer
por: Harachi, Mio, et al.
Publicado: (2021) -
mTOR Complexes as a Nutrient Sensor for Driving Cancer Progression
por: Harachi, Mio, et al.
Publicado: (2018) -
GEN-14 Dual regulation of histone methylation by mTOR complexes drives the progression of EGFR-mutant glioblastoma
por: Masui, Kenta, et al.
Publicado: (2020) -
The metabolomic landscape plays a critical role in glioma oncogenesis
por: Masui, Kenta, et al.
Publicado: (2022) -
mTORC2 dictates Warburg effect and drug resistance
por: Masui, Kenta, et al.
Publicado: (2014)